Atlas Trials

Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus

Clinical trial NCT04065230 · UNKNOWN

Trial details

NCT number
NCT04065230
Sponsor
Southeast University, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatitis B VirusMother to Child Transmission
Start date
2019-08-01
Primary completion
2021-08-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.